Core Viewpoint - The listing plans of Chinese company Xiaoyu Dida in the U.S. have changed due to its partner SPAC, Four Leaf Acquisition Corp, being delisted from Nasdaq and moving to OTC trading, alongside three other SPACs involving Chinese companies facing similar situations [1] Group 1: Regulatory Changes - Nasdaq's new regulations effective January 17, 2026, significantly raise the listing thresholds for SPACs, contributing to a cautious attitude from capital towards Chinese SPAC projects [1] Group 2: Market Trends - The financing scale for Chinese companies listing in the U.S. has decreased by 41% year-on-year as of mid-2025, further exacerbating the cautious approach from investors [1] Group 3: OTC Market Opportunities - The OTC market is emerging as a new option for cross-border financing for Chinese companies due to its lower thresholds, reduced costs, simplified approval processes, and more lenient information disclosure requirements [1] - Institutions like Edenhall Global Capital are assisting Chinese companies in achieving cross-border capital operations through the OTC market [1]
快讯｜SPAC模式遇阻 中企赴美上市转向OTC市场
Sou Hu Cai Jing·2026-01-21 03:45